Wall Street is positive on HIVE Blockchain Technologies Ltd (HIVE). On average, analysts give HIVE Blockchain Technologies Ltd a Strong Buy rating. The average price target is $3.483, which means analysts expect the stock to gain by 300.34% over the next twelve months.
That average ranking earns HIVE Blockchain Technologies Ltd an Analyst Rating of 63, which is better than 63% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating HIVE a Strong Buy today. Find out what this means to you and get the rest of the rankings on HIVE!
Why are Analyst Ratings Important?
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What's Happening With HIVE Blockchain Technologies Ltd Stock Today?
HIVE Blockchain Technologies Ltd (HIVE) stock is down -6.35% while the S&P 500 is higher by 0.16% as of 1:33 PM on Monday, May 16. HIVE has fallen -$0.06 from the previous closing price of $0.93 on volume of 3,451,708 shares. Over the past year the S&P 500 is lower by -3.20% while HIVE has fallen -66.15%. HIVE lost -$0.41 per share the over the last 12 months.
Click Here to get the full Stock Report for HIVE Blockchain Technologies Ltd stock.